Loading...
Loading...
Browse all stories on DeepNewz
VisitDupixent approved for COPD in US by end of 2024?
Yes • 50%
No • 50%
FDA (Food and Drug Administration) official announcements
Sanofi and Regeneron’s Dupixent Approved for COPD, 'Smoker's Lungs,' in EU
Jul 3, 2024, 05:15 AM
Sanofi and its partner Regeneron have received European Union approval on Wednesday for the expanded use of their Dupixent injection to treat patients with chronic obstructive pulmonary disease (COPD). This marks the first-ever targeted therapy for COPD, also referred to as 'smoker's lungs,' approved in the EU. Notably, the EU's approval process for Dupixent was faster than that of the United States, highlighting a rare instance of expedited clearance. The approval is expected to create a new growth avenue for the blockbuster drug.
View original story
Less than 10% • 25%
10% to 20% • 25%
20% to 30% • 25%
More than 30% • 25%
0 • 25%
1 • 25%
2 • 25%
3 or more • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Approved in 5 or more additional regions • 34%
Approved in 1-2 additional regions • 33%
Approved in 3-4 additional regions • 33%
Less than 10% • 25%
10% to 20% • 25%
20% to 30% • 25%
More than 30% • 25%